Insulin aspart, recombinant Subcutaneous and Lincomycin
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lincomycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lincomycin
Brand name: Lincocin, Lincorex, L-Mycin, Bactramycin
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lincomycin Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Lincomycin Injection
- Insulin aspart, recombinant Subcutaneous-Lincomycin Oral, Injection
- Insulin aspart, recombinant Subcutaneous-Lindane
- Insulin aspart, recombinant Subcutaneous-Lindane Lotion
- Insulin aspart, recombinant Subcutaneous-Lindane Shampoo
- Lincomycin-Insulin degludec
- Lincomycin-Insulin Degludec (U-100) Prefilled Pens
- Lincomycin-Insulin Degludec (U-100) Vials
- Lincomycin-Insulin Degludec (U-200) Prefilled Pens
- Lincomycin-Insulin degludec and liraglutide
- Lincomycin-Insulin degludec and liraglutide Subcutaneous